Osteoporosis, Arthritis and Musculoskeletal Disorders

COVID-19 and arthritis

The global pandemic of coronavirus disease 2019 (COVID-19) has resulted in severe morbidity and mortality. During the pandemic, patients with arthritis confront specific obstacles, including infection risk, medicine shortages, restricted access to care, social isolation, and mental health issues. The impact of the COVID-19 pandemic on people with arthritis will be examined in this review. Older age and comorbidities are risk factors for catastrophic COVID-19 outcomes in arthritis patients, just as they are in the general population. Glucocorticoids appear to be linked to a greater risk of severe COVID-19 outcomes, but not other kinds of disease-modifying anti rheumatic medications (DMARDs). Changes in access to care, telemedicine, prescription shortages, anxiety, and social isolation have all impacted arthritis sufferers, perhaps contributing to disease flares.